Displaying 1 - 2 of 2
Author:Hartung, Hans-Peter Holmoy, Trygve Wuerfel, Jens Heer, Yanic Braune, Stefan Bergmann, Arnfin Zuercher, Mel Guye, Sabrina Kuenzel, Thomas Moore, Suzanne Vollmer, Timothy
Session Name:P9: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 2
Topic:Multiple Sclerosis
Program Number:P9.005
Author Institution:Department of Neurology, UKD, Centre of Neurology and Neuropsychiatry and LVR-Klinikum, Heinrich-Heine University, Dusseldorf, Germany Akershus University Hospital, Nordbyhagen, Norway Roche PDMA Neuroscience, Basel, Switzerland PricewaterhouseCoopers AG, Zurich, Switzerland NeuroTransData, Neuburg an der Donau, Germany F. Hoffmann-La Roche Ltd., Basel, Switzerland University of Colorado, Aurora, CO
Author:Vollmer, Timothy Bermel, Robert Brochet, Bruno Berger, Thomas Carroll, William Freedman, Mark Holmoy, Trygve Karabudak, Rana Killestein, Joep Nos, Carlos Patti, Francesco Vanopdenbosch, Ludo Kuenzel, Thomas Kadner, Karen Kulyk, Inessa Hartung, Hans-Peter
Session Name:P10: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 3
Topic:Multiple Sclerosis
Program Number:P10.007
Author Institution:University of Colorado, Aurora, CO Cleveland Clinic, Cleveland, OH Université de Bordeaux, Neurocentre Magendie INSERM, Bordeaux, France Dept. of Neurology, Medical University of Vienna, Vienna, Austria The University of Western Australia, Nedlands, Australia University of Ottawa, Ottawa, ON, Canada Akershus University Hospital, Lorenskog, Norway Hacettepe University Faculty of Medicine, Ankara, Turkey VU University Medical Centre, Amsterdam, Netherlands Vall d’Hebron Hospital Universitari, Barcelona, Spain University of Catania PO Policlinico G Rodolico, Catania, Italy AZ Sint-Jan Brugge, Brugge, Belgium F. Hoffmann-La Roche Ltd., Basel, Switzerland Department of Neurology, Heinrich-Heine University, Dusseldorf, Germany
Displaying 1 - 2 of 2